Sporadic Papillary Renal Cell Cancer
1 clinical trials · Condition
◉ Watch Sporadic Papillary Renal Cell Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer (NCT01130519) | National Cancer Institute (NCI) | 2010-05-06 |
Track Sporadic Papillary Renal Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.